Potential molecular marker for detecting transitional cell carcinoma

被引:31
作者
Chiu, AW
Huang, YL
Huan, SK
Wang, YC
Ju, JP
Chen, MF
Chou, CK
机构
[1] Chi Mei Med Ctr, Div Urol, Dept Surg, Tainan 71070, Taiwan
[2] Chi Mei Med Ctr, Dept Med Res, Tainan 71070, Taiwan
[3] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
[4] Vet Gen Hosp, Dept Med Res, Taipei 11217, Taiwan
[5] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan
关键词
D O I
10.1016/S0090-4295(02)01672-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To assess the expression rate of a cancer-related gene, hepatoma-up-regulated protein (HURP), in the tumor tissue of transitional cell carcinoma (TCC), and to assess the potential suitability of using this gene as a novel molecular marker for detecting TCC in voided urine. Methods. Total RNA was extracted from 80 TCC tissue samples of the urinary tract. Forty-five of the 80 tumor-adjacent tissue samples were from the same patients and 15 were from control subjects (patients with benign prostatic hyperplasia). The expression levels of HURP mRNA in these specimens were examined using reverse transcriptase-polymerase chain reaction. The HURP mRNA transcripts in voided urine pellets from 14 additional patients were determined using the same method. The messages were normalized to beta-actin mRNA. Results. The detection of HURP expression in the TCC tissue samples had a sensitivity of 88.8% (71 of 80) and a specificity of 100% (15 of 15). Ten of the 45 grossly tumor-adjacent tissue samples expressed HURP mRNA, which may indicate subtle genetic changes in tissue adjacent to tumor. All seven urine specimens from the patients with TCC revealed HURP expression; however, no specimens from patients with nonmalignant diseases did so. Conclusions. A potential molecular marker for detecting TCC with tissue specimens and voided urine samples has been found. Although the real clinical application of this marker requires additional evaluation, the high sensitivity and specificity of the HURP gene amplification method warrants more investigation in the future. (C) 2002, Elsevier Science Inc.
引用
收藏
页码:181 / 185
页数:5
相关论文
共 18 条
  • [1] Characterization of a novel human cell-cycle-regulated homologue of Drosophila dlg1
    Bassal, S
    Nomura, N
    Venter, D
    Brand, K
    McKay, MJ
    van der Spek, PJ
    [J]. GENOMICS, 2001, 77 (1-2) : 5 - 7
  • [2] TNM (1978) IN BLADDER-CANCER - USE AND ABUSE
    CHISHOLM, GD
    HINDMARSH, JR
    HOWATSON, AG
    WEBB, JN
    BUSUTTIL, A
    HARGREAVE, TB
    NEWSAM, JE
    [J]. BRITISH JOURNAL OF UROLOGY, 1980, 52 (06): : 500 - 505
  • [3] DROLLER MJ, 1990, CONT UROL JUL, P54
  • [4] Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors
    Ellis, WJ
    Blumenstein, BA
    Ishak, LM
    Enfield, DL
    [J]. UROLOGY, 1997, 50 (06) : 882 - 887
  • [5] The World Health Organization International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder
    Epstein, JI
    Amin, MB
    Reuter, VR
    Mostofi, FK
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (12) : 1435 - 1448
  • [6] Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma
    Hartmann, A
    Moser, K
    Kriegmair, M
    Hofstetter, A
    Hofstaedter, F
    Knuechel, R
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (03) : 721 - 727
  • [7] Konety BR, 2000, CLIN CANCER RES, V6, P2618
  • [8] Urine based markers of urological malignancy
    Konety, BR
    Getzenberg, RH
    [J]. JOURNAL OF UROLOGY, 2001, 165 (02) : 600 - 611
  • [9] Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27
  • [10] Screening and monitoring for bladder cancer: Refining the use of NMP22
    Ponsky, LE
    Sharma, S
    Pandrangi, L
    Kedia, S
    Nelson, D
    Agarwal, A
    Zippe, CD
    [J]. JOURNAL OF UROLOGY, 2001, 166 (01) : 75 - 78